" class="no-js "lang="en-US"> Nexus Pharmaceuticals Announces launch of Sterile Vials Product
Friday, March 31, 2023

Nexus Pharmaceuticals Announces Launch of Sterile Vial Product Line

Nexus Pharmaceuticals announced the launch of its new product line – Sterile Vials from Nexus Pharmaceuticals. The product trio includes 20mL clear vials, 10mL clear vials, and 2mL amber vials with plans to expand the portfolio with a wider range of sizes.

“This development aligns with Nexus’ commitment to innovation and represents a progressive step in broadening our healthcare scope and addressing supply chain constraints in the market,” said Omair Ahmed, Chief Operating Officer of Nexus Pharmaceuticals. “We have designed this product for use in various settings, including research laboratories, healthcare clinics, and veterinary offices. This direct-to-consumer offering is a new and exciting venture for us, and we look forward to a closer relationship with our customers.”

The sterilized vials from Nexus Pharmaceuticals are available for purchase in cartons consisting of twenty-five vials. The pyrogen-free glass vials are manufactured at an FDA-inspected facility under GMP conditions. They feature FluroTec® Barrier Film technology, providing an effective barrier against extractables and leachables and minimizing the risk of impurities, interactions, and medicine degradation. The finished vial stoppers are composed of a latex- and rubber-free chlorobutyl formulation.

  1. Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Read more
  2. Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Read more
  3. Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Read more
  4. Hansa Biopharma Completes Enrollment in Phase 2 Study of Imlifidase in Guillain-Barré Syndrome (GBS) Read more
  5. ProJenX Announces Formation of Scientific Advisory Board for Development of ALS Treatment Read more